SOUNG, J.; TIU, L.; VEVERKA, K.; HONG, C.-H. Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s26, 2017. DOI: 10.25251/skin.1.supp.25. Disponível em: https://jofskin.org/index.php/skin/article/view/172. Acesso em: 3 jul. 2024.